Home/United Immunity/Harada

H

Harada

Founding Scientist & Chief Technology Officer

United Immunity

Therapeutic Areas

Oncology Immunology Infectious Disease Fibrosis Metabolic Disease

United Immunity Pipeline

Drug	Indication	Phase
UI-102	Solid Tumors	Phase 1
UI-201	Not Specified	Preclinical
Next-gen COVID-19 Vaccine	COVID-19	Preclinical
Platform Programs	Various (Cancer, Fibrosis, Autoimmunity)	Research

Leadership Team at United Immunity

Chief Scientific Officer

Yvette van Kooyk

Scientific Advisory Board Member

View full United Immunity profile